PET/CT scan to study neural crest tumors
Treatments studied
Part of Cancer clinical trials.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) can sign an informed consent form before any study tests.
- You have a confirmed or strongly suspected neural crest tumor, such as neuroblastoma.
- If you have neuroblastoma, you had an iodine MIBG scan (planar plus SPECT/CT) within the last 6 months or it’s planned within 3 months.
- You must be able and willing to follow all study scan and visit steps described in the protocol.
- You must not be pregnant or breastfeeding during the study (pregnancy tests are done if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This study compares two types of imaging scans to see which is better at finding neuroblastoma in children. Your child will get both a standard MIBG scan and a newer PET scan, and the results will be compared to help improve future detection.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This trial tests a new type of PET/CT scan called [68Ga]Ga-FAPI-04 to see if it can better detect high-grade neuroendocrine tumors. It is for patients whose standard scans show low uptake or who have aggressive tumor features.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.